Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
HEALIOS K.K. Announces Nominees for Upcoming Shareholders' Meeting
Disclosure time: February 20, 2026
HEALIOS K.K. [4593.T]
TOKYO, Feb 20 (Pulse News Wire) – HEALIOS K.K. (4593.T) announced today that its board of directors meeting held, resolved to nominate candidates for the upcoming 15th regular shareholders’ general meeting scheduled for March 25, 2026. The nominees include: - Kazuhisa Kagimoto, President and CEO - Masao Sakurai, outside director - Richard Kincaid, CFO - Yugo Yogo, outside director - Glenn Gormley, outside director Additionall
TOKYO, Feb 20 (Pulse News Wire) – HEALIOS K.K. (4593.T) announced today that its board of directors meeting held, resolved to nominate candidates for the upcoming 15th regular shareholders’ general meeting scheduled for March 25, 2026. The nominees include: - Kazuhisa Kagimoto, President and CEO - Masao Sakurai, outside director - Richard Kincaid, CFO - Yugo Yogo, outside director - Glenn Gormley, outside director Additionally, the company has nominated Tamura Kouichi as a potential alternate director should there be a shortfall in the number of statutory directors.
